Arcadia Biosciences, Inc.
RKDA
$3.40
-$0.0813-2.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -251.93% | 143.79% | 15.07% | -11.14% | -411.91% |
| Total Depreciation and Amortization | -24.88% | -8.33% | 2.70% | -16.85% | 9.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 98.38% | -760.43% | -56.77% | -30.39% | 94.98% |
| Change in Net Operating Assets | -73.19% | 76.92% | 50.50% | -217.06% | 78.88% |
| Cash from Operations | 28.66% | 23.49% | 21.80% | -42.29% | 39.87% |
| Capital Expenditure | 100.00% | 76.92% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | 24.14% | 752.94% | -76.71% | 1,360.00% | -28.57% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -- | -- | 100.00% |
| Cash from Investing | -96.12% | 115,975.00% | -92.31% | 940.00% | 100.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.70% | 168.32% | 21.02% | -41.07% | 69.80% |
